Skip to main content

Table 4 Patient characteristics methylnaltrexone trial

From: Optimal treatment of opioid induced constipation in daily clinical practice – an observational study

  Total
N = 26
Oxycodone group
N = 16
Fentanyl group
N = 8
Morphine group
N = 2
Age mean (SD) 59 (13) 58 (10) 58 (18) 62 (18)
Sex Male 11 9 2 0
Female 15 7 6 2
Treatment setting Hospital 20 11 7 2
Ambulant 6 5 1 0
Cancer Type Gastro-intestinal 9 6 3 0
Breast 6 3 2 1
Genito-urethral 6 5 1 0
Other 5 2 2 1
Concomitant laxatives PEG 19 12 5 2
Magnesiumoxide 7 4 3 0
Other 3 3 0 0
Patients using > 1 laxative   4 3 1 0
Morphine equivalent daily dose median (range) 80 (40–540) 80 (40–160) 120 (60–240) 525 (510–540)
  1. PEG polyethylene glycol solution